AzTrials
AzTrials

Frequency of Chromosome AberrationsNCT00341900

Study of Markers of Cosmic Radiation Exposure and Effect Among Flight Crews

An observational study of Frequency of Chromosome Aberrations, run by National Cancer Institute (NCI) at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Ionizing radiation efficiently induces chromosomal aberrations (CA) and several studies of CA have now been conducted among small groups of flight crews. However, most of the studies only evaluated the unstable aberrations that reflect recent exposures, but not long-term cumulative cosmic radiation exposure. Read more about this study

Who is it for?
Ages 25 to 60 years, men only
Conditions the study is for
Frequency of Chromosome Aberrations
How many people
134 participants
Where
1 siteUnited States
Study dates
9 Nov 2001to 3 Apr 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 60 years
  • Men only
  • No healthy volunteers
  • Adult

Study population: Pilots estimated to have high comic radiation exposure based on flight histories.

Who may be able to join

  • PILOTS:
  • Subjects will be Chicago based pilots who fly international flights out of Chicago.
  • Subjects must have worked at least 10 years as an international pilot.
  • EXTERNAL COMPARISON GROUP:
  • Subjects must be currently employed as university faculty from the Chicago area.
  • Pilots and External Comparison Group Subjects:
Show all 9Show fewer
  • Age 35-54.
  • Non-Smoker (less than 100 lifetime cigarettes).
  • Male.

Who cannot join

  • PILOTS AND EXTERNAL COMPARISON GROUP SUBJECTS:
  • No personal history of cancer.
  • No history of chemotherapy.
  • No history of major diagnostic radiation therapy (e.g., radio-imaging that exposed the large bones or lymph nodes except for routine medical and dental x-rays).
  • No family history of hereditary diseases (ataxia telangiectasia, Fanconi's anemia, Bloom's syndrome, and xeroderma pigmentosum).
  • EXTERNAL COMPARISON GROUP SUBJECTS:
Show all 9Show fewer
  • Must not have a history of excessive past air travel (defined as no more than an average of one international flight/year and one domestic flight/month).
  • No history of major illnesses, such as heart disease and diabetes.
  • Must not have been employed in a clinical or laboratory area that involves exposure to radiation and chemotherapeutic drugs.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • National Institute for Occupational Safety and Health

    Cincinnati, Ohio, 26505-2888

Other trials in United States

About this study

Ionizing radiation efficiently induces chromosomal aberrations (CA) and several studies of CA have now been conducted among small groups of flight crews. However, most of the studies only evaluated the unstable aberrations that reflect recent exposures, but not long-term cumulative cosmic radiation exposure. Chromosome painting by fluorescence in situ hybridization (FISH) is a widely used and established cytogenetic method for detecting stable aberrations such as translocations. Thus, FISH can be used for estimating chromosomal damage from cumulative radiation exposure. No large studies of flight crews utilizing FISH have been conducted to date.

We propose a study to measure CA using FISH in a group of pilots estimated to have high comic radiation exposure based on flight histories, i.e., those with long duration flying international routes, and a comparison group of university faculty with minimal flying history. These measurements will be used to determine if pilots have elevated frequencies of CA (specifically stable translocations) as compared with the university faculty. In addition, the frequencies of CA will be examined in relation to the cumulative cosmic radiation dose to determine if there is a dose-response relationship. Individual cumulative doses will be calculated from pilot flight histories using a computer program developed by the FAA which estimates cosmic radiation does by accounting for changes in altitude and latitude, and the 11-year solar cycle at the time of the flight. We will collect information on age, lifestyle factors, diet, health history, family cancer history, and medical radiation exposures from personal interview and self-administered dietary questionaire. These factors may affect the CA frequency and so we plan to adjust for them in the statistical analyses.

Pilots will be identified based on the Allied Pilots Association roster and faculty from a commercial company that maintains a database of university faculty, including those in the Chicago area. Potential participants will be notified of the study by mail and recruited/screened for eligibility over the telephone. We will compensate participants $100 for their time. A field station will be set up at a medical or health clinic convenient to the participants, where interviews Will be conducted and a peripheral blood sample collected. Participants will be notified of the overall study results and may request their personal CA results at the end of the study. Participants may also choose to have additional blood drawn, however this blood sample will be anonymized so that it cannot be linked back to the participant. Genotypic variants in DNA repair (and possibly other) genes will be evaluated for an effect on CA frequency.

Read the detailed description

Ionizing radiation efficiently induces chromosomal aberrations (CA) and several studies of CA have now been conducted among small groups of flight crews. However, most of the studies only evaluated the unstable aberrations that reflect recent exposures, but not long-term cumulative cosmic radiation exposure. Chromosome painting by fluorescence in situ hybridization (FISH) is a widely used and established cytogenetic method for detecting stable aberrations such as translocations. Thus, FISH can be used for estimating chromosomal damage from cumulative radiation exposure. No large studies of flight crews utilizing FISH have been conducted to date.

In collaboration with the National Institute for Occupational Safety and Health (NIOSH), we proposed a study to measure CA using FISH in a group of pilots estimated to have high comic radiation exposure based on flight histories, i.e., those with long duration flying international routes, and a comparison group of university faculty with minimal flying history. These measurements will be used to determine if pilots have elevated frequencies of CA (specifically stable translocations) as compared with the university faculty. In addition, the frequencies of CA will be examined in relation to the cumulative cosmic radiation dose to determine if there is a dose-response relationship. Individual cumulative doses will be calculated from pilot flight histories using a computer program developed by the FAA which estimates cosmic radiation does by accounting for changes in altitude and latitude, and the 11-year solar cycle at the time of the flight. We will collect information on age, lifestyle factors, diet, health history, family cancer history, and medical radiation exposures from a self-administered study and dietary questionnaire. These factors may affect the CA frequency and so we plan to adjust for them in the statistical analyses.

Pilots were identified based on the Allied Pilots Association roster and faculty from a commercial company that maintains a database of university faculty, including those in the Chicago area. Potential participants will be notified of the study by mail and recruited/screened for eligibility over the telephone. We compensated participants $100 for their time and inconvenience. Two field stations were arranged at the O'Hare UIC medical clinic for pilots and at the UIC Health Services clinic (on campus) for the faculty, where interviews were conducted and a peripheral blood sample collected. Participants will be notified of the overall study results and may request their personal CA results at the end of the study. Participants may also choose to have additional blood drawn, however this blood sample will be anonymized so that it cannot be linked back to the participant. Genotypic variants in DNA repair (and possibly other) genes will be evaluated for an effect on CA frequency.

Keywords
Chromosome Translocations, Cosmic Radiation, Airline Flight Crew, Airlines, Flight Crew, Occupational Exposure
Medical subject headings
Translocation, Genetic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT00341900
Study groupRoleWhat they receive
CaseMale pilots with high cosmic radiation exposure

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Chromosome translocation frequency

    Chromosome translocation frequency

    Measured: One time point

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jun 2006 (estimated)
  2. Study start9 Nov 2001
  3. Primary completion31 Dec 2016
  4. Study completion3 Apr 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
134 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00341900
Sponsor's protocol ID
999902043
Other IDs
02-C-N043
Status last verified
Apr 2020
First submitted
19 Jun 2006
Last updated
7 Apr 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Yong LC, Sigurdson AJ, Ward EM, Waters MA, Whelan EA, Petersen MR, Bhatti P, Ramsey MJ, Ron E, Tucker JD. Increased frequency of chromosome translocations in airline pilots with long-term flying experience. Occup Environ Med. 2009 Jan;66(1):56-62. doi: 10.1136/oem.2008.038901. Epub 2008 Dec 11.

    PubMed 19074211
  • Grajewski B, Waters MA, Yong LC, Tseng CY, Zivkovich Z, Cassinelli RT 2nd. Airline pilot cosmic radiation and circadian disruption exposure assessment from logbooks and company records. Ann Occup Hyg. 2011 Jun;55(5):465-75. doi: 10.1093/annhyg/mer024. Epub 2011 May 24.

    PubMed 21610083
  • Yong LC, Petersen MR, Sigurdson AJ, Sampson LA, Ward EM. High dietary antioxidant intakes are associated with decreased chromosome translocation frequency in airline pilots. Am J Clin Nutr. 2009 Nov;90(5):1402-10. doi: 10.3945/ajcn.2009.28207. Epub 2009 Sep 30.

    PubMed 19793852

Questions about this trial

What is this clinical trial studying?

An observational study of Frequency of Chromosome Aberrations, run by National Cancer Institute (NCI) at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Apr 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Chromosome translocation frequency (time frame: One time point). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00341900, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Apr 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in